Oxaliplatin as First-Line Treatment in Inoperable Biliary Tract Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|70|4|280-284

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.4, 2006-10, pp. : 280-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 356-360

Karger

Access to resources Recommend Favorite

Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 359-365

Karger

Access to resources Recommend Favorite

Oxaliplatin, Irinotecan and Capecitabine (OCX) for First-Line Treatment of Advanced/Metastatic Colorectal Cancer: A Phase I Trial (SAKK 41/03)

By  

Oncology Research and Treatment, Vol. 33, Iss. 6, 2010-05 ,pp. : 295-299

Karger

Access to resources Recommend Favorite

5-Fluorouracil, Leucovorin and Oxaliplatin plus Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer: A Single-Institute Study

By  

Oncology, Vol. 72, Iss. 1-2, 2007-10 ,pp. : 4-9

Karger

Access to resources Recommend Favorite

Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 350-355

Karger

Access to resources Recommend Favorite